News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
725,426 Results
Type
Article (49253)
Company Profile (316)
Press Release (675857)
Section
Business (212054)
Career Advice (2087)
Deals (36492)
Drug Delivery (98)
Drug Development (83428)
Employer Resources (169)
FDA (16904)
Job Trends (15672)
News (358770)
Policy (34610)
Tag
Academia (2758)
Alliances (51363)
Alzheimer's disease (1309)
Approvals (16851)
Artificial intelligence (160)
Bankruptcy (364)
Best Places to Work (12041)
Biotechnology (218)
Breast cancer (194)
Cancer (1405)
Cardiovascular disease (117)
Career advice (1750)
Cell therapy (286)
Clinical research (66600)
Collaboration (496)
Compensation (261)
COVID-19 (2667)
C-suite (115)
Data (1408)
Diabetes (178)
Diagnostics (6383)
Earnings (87010)
Employer resources (147)
Events (114963)
Executive appointments (403)
FDA (17595)
Funding (438)
Gene therapy (199)
GLP-1 (647)
Government (4603)
Healthcare (19778)
Infectious disease (2762)
Inflammatory bowel disease (116)
Interviews (317)
IPO (16705)
Job creations (4040)
Job search strategy (1497)
Layoffs (436)
Legal (8415)
Lung cancer (205)
Lymphoma (99)
Manufacturing (212)
Medical device (14209)
Medtech (14214)
Mergers & acquisitions (19944)
Metabolic disorders (484)
Neuroscience (1645)
NextGen Class of 2024 (6900)
Non-profit (4727)
Northern California (1707)
Obesity (280)
Opinion (197)
Patents (118)
People (59294)
Phase I (20693)
Phase II (29269)
Phase III (21874)
Pipeline (517)
Postmarket research (2738)
Preclinical (8832)
Radiopharmaceuticals (246)
Rare diseases (265)
Real estate (6287)
Regulatory (23072)
Research institute (2472)
Resumes & cover letters (359)
Southern California (1474)
Startups (3817)
United States (15515)
Vaccines (601)
Weight loss (207)
Date
Last 7 days (603)
Last 30 days (2391)
Last 365 days (36061)
2024 (35895)
2023 (41150)
2022 (52383)
2021 (57104)
2020 (55918)
2019 (48800)
2018 (36939)
2017 (33752)
2016 (33572)
2015 (39620)
2014 (33327)
2013 (28559)
2012 (30852)
2011 (31556)
2010 (29929)
Location
Africa (789)
Arizona (203)
Asia (40421)
Australia (6659)
California (3852)
Canada (1456)
China (311)
Colorado (179)
Connecticut (189)
Europe (87454)
Florida (537)
Georgia (143)
Illinois (415)
Indiana (229)
Maryland (655)
Massachusetts (3025)
Michigan (177)
Minnesota (301)
New Jersey (1120)
New York (1094)
North Carolina (801)
Northern California (1707)
Ohio (147)
Pennsylvania (929)
South America (1180)
Southern California (1474)
Texas (560)
Utah (111)
Washington State (410)
725,426 Results for "spectral medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders
Spectral Medical Inc., a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, announced the results of its Annual Meeting of shareholders.
June 7, 2024
·
3 min read
Press Releases
Spectral Medical Provides November Tigris Trial Update
December 2, 2024
·
4 min read
Business
Spectral Medical Chair to Retire From the Board of Directors
Spectral Medical Inc. announced that Anthony Bihl III, Spectral’s Chairman, will be retiring from the Board at Spectral’s upcoming Shareholder Meeting in June 2024.
April 2, 2024
·
3 min read
Press Releases
Spectral Medical Provides October Tigris Trial Update
November 5, 2024
·
3 min read
Business
Spectral Medical Announces First Quarter 2024 Results and Provides Corporate Update
Spectral Medical Inc., a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, announced its financial results for the first quarter ended March 31, 2024, and provided a corporate update.
May 13, 2024
·
13 min read
Press Releases
Spectral Medical Announces Third Quarter Results and Provides Corporate Update
November 8, 2024
·
16 min read
Spectral Medical Provides April 2024 Tigris Trial Update
Spectral Medical Inc., a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, provided an update on the Company’s Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion in a randomized controlled trial of adults treated for endotoxemia and septic shock.
May 6, 2024
·
3 min read
Drug Development
Spectral Medical Provides Tigris Trial Update - April 10, 2024
Spectral Medical Inc., a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, provided an update on the Company’s Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion in a randomized controlled trial of adults treated for endotoxemia and septic shock.
April 10, 2024
·
3 min read
Drug Development
Spectral Medical Provides February Tigris Trial Update
Spectral Medical Inc. today provided an update on the Company’s Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion (“PMX”) in a randomized controlled trial of adults treated for endotoxemia and septic shock.
February 28, 2024
·
3 min read
Press Releases
Spectral Medical Provides August Tigris Trial Update
September 3, 2024
·
4 min read
1 of 72,543
Next
